Correlation Between LIFE Old and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both LIFE Old and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIFE Old and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LIFE Old and Neoleukin Therapeutics, you can compare the effects of market volatilities on LIFE Old and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIFE Old with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIFE Old and Neoleukin Therapeutics.
Diversification Opportunities for LIFE Old and Neoleukin Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between LIFE and Neoleukin is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding LIFE Old and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and LIFE Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIFE Old are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of LIFE Old i.e., LIFE Old and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between LIFE Old and Neoleukin Therapeutics
Given the investment horizon of 90 days LIFE Old is expected to under-perform the Neoleukin Therapeutics. In addition to that, LIFE Old is 1.21 times more volatile than Neoleukin Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 63.00 in Neoleukin Therapeutics on November 1, 2024 and sell it today you would earn a total of 6.00 from holding Neoleukin Therapeutics or generate 9.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 33.73% |
| Values | Daily Returns |
LIFE Old vs. Neoleukin Therapeutics
Performance |
| Timeline |
| LIFE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
LIFE Old and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LIFE Old and Neoleukin Therapeutics
The main advantage of trading using opposite LIFE Old and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIFE Old position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| LIFE Old vs. Mereo BioPharma Group | LIFE Old vs. Terns Pharmaceuticals | LIFE Old vs. PDS Biotechnology Corp | LIFE Old vs. Inozyme Pharma |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |